|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Esophageal cancer显示文摘 | Enzinger PC Mayer RJ | 2003 | N Eng J Med2003，349，： | 1 |
| 2 | Phase II trial of docetaxel,cisplatin,irinotecan,and bevacizumab in metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Regan EM | 2008 | J Clin Oncol2008，，： | 1 |
| 3 | Esophageal cancer 显示文摘 | Enzinger PC Mayer RJ | 2003 | N Engl J Med2003，349，23： | 1 |
| 4 | Chemotherapy in esophagealcancer显示文摘 | Enzinger PC Ilson DH Kelsen DP | 1999 | Semin Oncol1999，26，： | 1 |
| 5 | Phase Ⅱ study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors显示文摘 | Kulke MH Stuart K Enzinger PC | 2006 | J Clin Oncol2006，24，： | 1 |
| 6 | Phase Ⅱ study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC) 显示文摘 | Meyerhardt JA Xhu A Enzinger PC | 2004 | J Clin Oncol2004，22，： | 1 |
| 7 | Weekly docetaxel,cisplatin,and irinotecan(TPC):results of a multicenter phase Ⅱ trial in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 8 | Phase Ⅱ study of capecitabine,oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC)显示文摘 | Meyerhardt JA Zhu A Enzinger PC | 2006 | J Clin Oncol2006，24，12： | 1 |
| 9 | NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘 | Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C | 2009 | J Natl Compr Canc Netw2009，7，： | 1 |
| 10 | Phase Ⅱ study of capecitabine,oxaliplatin,and erlotinib in previously treated patients with metastastic colorectal cancer显示文摘 | Meyerhardt JA Zhu AX Enzinger PC | 2006 | J Clin Oncol2006，24，12： | 1 |
| 11 | Chemotherapy in esophageal cancer显示文摘 | Enzinger PC Ilson DH Kelsen DP | 1999 | Semin Oncol1999，26，515： | 1 |
| 12 | Phase II trial of docetaxel, cisplatin, irinotecan, and bevacizumab in metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Regan EM | 2008 | J Clin Oncol2008，26，： | 1 |
| 13 | Esophageal cancer显示文摘 | Enzinger PC Mayer FIJ | 2003 | N Engl JMed2003，349，23： | 1 |
| 14 | Chemotherapy in esophageal cancer 显示文摘 | Enzinger PC Ⅱ son DH Kelse DP | 1999 | Semin Oncol1999，26，515： | 1 |
| 15 | Phase Ⅱ study of capecitabine,oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC)显示文摘 | Meyerhardt JA Xhu A Enzinger PC | 2004 | J Clin Oncol2004，22，： | 1 |
| 16 | Esophageal cancer 显示文摘 | Enzinger PC & Mayer RJ | 2003 | 5/ Eng! J Med2003，349，： | 1 |
| 17 | Phase Ⅱ study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer显示文摘 | Meyerhardt JA Zhu AX Enzinger PC | 2006 | J Clin Oncol2006，24，12： | 1 |
| 18 | Esophageal cancer显示文摘 | Enzinger PC Mayer RJ | 2003 | N Engl J Med2003，349，23： | 1 |
| 19 | Esophageal cancer显示文摘 | Enzinger PC Mayer RJ | 2003 | N Engl J Med2003，349，： | 1 |
| 20 | A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma显示文摘 | Chan JA Blaszkowsky LS Enzinger PC | | 0，，06： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员